88511801 - CRISPRBIOTIC

Information

  • Trademark
  • 88511801
  • Serial Number
    88511801
  • Registration Number
    6083472
  • Filing Date
    July 12, 2019
    5 years ago
  • Registration Date
    June 23, 2020
    4 years ago
  • Transaction Date
    June 23, 2020
    4 years ago
  • Status Date
    June 23, 2020
    4 years ago
  • Published for Opposition Date
    April 07, 2020
    4 years ago
  • Location Date
    June 23, 2020
    4 years ago
  • Status Code
    700
  • Current Location
    PUBLICATION AND ISSUE SECTION
    Employee Name
    THOMAS, JULIE
  • Attorney Docket Number
    86291.020199
    Attorney Name
    Mark H. Tidman
    Law Office Assigned Location Code
    L70
  • Owners
Mark Drawing Code
4000
Mark Identification
CRISPRBIOTIC
Case File Statements
  • GS0051: Pharmaceutical preparations, namely, antibacterial treatments, microbiome modulating treatments, anti-infective treatments and prophylaxis; medical preparations, namely, antibacterial treatments, microbiome modulating treatments, anti-infective treatments and prophylaxis, and medical diagnostics; veterinary preparations for antibacterial treatments, microbiome modulating treatments, anti-infective treatments and prophylaxis, and medical diagnostics; sanitary preparations for medical purposes; dietetic food and beverages adapted for medical or veterinary use; dietary supplements for human beings and animals; dietary supplements; antibiotic preparations; pharmaceutical preparations, namely, antiviral preparations; probiotic supplements; probiotic supplements for medical use; probiotic formulations for veterinary use, namely, probiotic nutritional supplements; probiotic formulations for medical use, namely, probiotic nutritional supplements; animal feed additives for use in animals feed to assist in digestion, growth or wellbeing; microbiome modulators for medical purposes, namely, targeted antimicrobial treatments for disease prevention or alteration; guided nuclease-based biocides; CRISPR-based biocides; pharmaceutical preparations for the treatment or prevention of disorders or diseases caused by bacteria
  • GS0421: Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; scientific and technological services, namely, scientific research, analysis and testing in the field of diseases and conditions associated with bacteria; industrial analysis and industrial research services; design and development of computer hardware and software; genetic microbiology and microbiome research; genetic engineering and services; design and development of hardware and software; clinical research; pharmaceutical research and development; development of pharmaceutical preparations and medicines; research and development services in the field of antibiotics; research and development of guided nuclease-based biocides; research and development of CRISPR-based biocides; research and development of CRISPR technology for the treatment of microbial diseases; clinical trials; clinical research; conducting clinical trials for pharmaceutical products; bacteriological research; viral research; biological research; scientific and medical screening and assaying; chemical analysis; chemical research
  • GS0441: Medical services; diagnostic and prognostic medical services; veterinary services; medical analysis services relating to the treatment of persons in the nature of diagnostic and treatment counseling regarding the treatment of medical conditions and disease; advice; medical and health services relating to DNA, genetics and genetic pathogen testing, namely, genetic testing for medical purposes; genetic counseling
Case File Event Statements
  • 6/23/2020 - 4 years ago
    16 - REGISTERED-PRINCIPAL REGISTER Type: R.PR
  • 4/7/2020 - 4 years ago
    15 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB
  • 4/7/2020 - 4 years ago
    14 - PUBLISHED FOR OPPOSITION Type: PUBO
  • 3/18/2020 - 5 years ago
    13 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP
  • 3/3/2020 - 5 years ago
    12 - LAW OFFICE PUBLICATION REVIEW COMPLETED Type: PREV
  • 3/2/2020 - 5 years ago
    11 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA
  • 2/1/2020 - 5 years ago
    10 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 2/1/2020 - 5 years ago
    9 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 1/31/2020 - 5 years ago
    8 - ASSIGNED TO LIE Type: ALIE
  • 1/28/2020 - 5 years ago
    7 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA
  • 9/28/2019 - 5 years ago
    6 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN
  • 9/28/2019 - 5 years ago
    5 - NON-FINAL ACTION E-MAILED Type: GNRT
  • 9/28/2019 - 5 years ago
    4 - NON-FINAL ACTION WRITTEN Type: CNRT
  • 9/28/2019 - 5 years ago
    3 - ASSIGNED TO EXAMINER Type: DOCK
  • 7/18/2019 - 5 years ago
    2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM Type: NWOS
  • 7/16/2019 - 5 years ago
    1 - NEW APPLICATION ENTERED IN TRAM Type: NWAP